Lack of coactivator interaction can be a mechanism for dominant negative activity by mutant thyroid hormone receptors

Endocrinology

Volumn 139, Issue 10, 1998, Pages 4197-4204

  Liu, Ying ^b   Takeshita, Akira ^a   Misiti, Silvia ^a   Chin, William W ^a   Yen, Paul M ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID HORMONE; THYROID HORMONE RECEPTOR;

ARTICLE; BINDING AFFINITY; DISSOCIATION; DNA BINDING; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; THYROID HORMONE RESISTANCE; TRANSACTIVATION;

EID: 0031734217     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.10.6218     Document Type: Article

References (45)

1. Refetoff S, Weiss RA, Usala SJ 1993 The syndromes of resistance to thyroid hormone. Endocr Rev 14:348-399
2. Collingwood TN, Adams N, Chatterjee VKK 1994 Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone beta-receptors in thyroid hormone resistance syndrome. Mol Endocrinol 8:1261-1277
3. Parrilla R, Mixson AJ, McPherson JA, McClasky JH, Weintraub BD 1991 Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain. J Clin Invest 88:2123-2130
4. Nagaya T, Madison LD, Jameson JL 1992 Thyroid hormone receptor mutants that cause resistance to thyroid hormone: evidence for receptor competition for DNA sequences in target genes. J Biol Chem 27:13014-13019
5. Yen PM, Sugawara A, Refetoff S, Chin WW 1992 New insights on the mechanism(s) of the dominant negative effect of mutant thyroid hormone receptor in generalized resistance to thyroid hormone. J Clin Invest 90:1825-1831
6. Yen PM, Wilcox EC, Hayashi Y, Refetoff S, Chin WW 1995 Studies on the repression of basal transcription (silencing) by artificial and natural thyroid hormone receptor-β mutants. Endocrinology 136:2845-2851
7. Chen JD, Evans RM 1995 A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457
8. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK, Rosenfeld MG 1995 Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear co-repressor. Nature 377:397-404
9. Lee JW, Choi HS, Gyuris J, Brent R, Moore DD 1995 Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Mol Endocrinol 9:243-254
10. Sande S, Privalsky ML 1996 Identification of TRACs, a family of cofactors that associate with, and modulate the activity of nuclear hormone receptors. Mol Endocrinol 10:813-825
11. Torchia J, Rose DW, Inostroza J, Kamei Y, Westin S, Glass CK, Rosenfeld MG 1997 The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387:677-736
12. Li H, Gomes PJ, Chen JD 1997 RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF 2. Proc Natl Acad Sci USA 94:8479-8484
13. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y, Evans RM 1997 Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90:569-580
14. Takeshita A, Cardona GR, Koibuchi N, Suen C-S, Chin WW 1997 TRAM-1, a novel 160 kDa thyroid hormone receptor coactivator molecule, exhibits distinct properties from steroid receptor coactivator-1. J Biol Chem 272:27629-27634
15. Aznick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan X-Y, Sauter G, Kallioniemi, Trent JM, Meltzer PS 1997 AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277:965-968
16. Onate SA, Tsai SY, Tsai MJ, O'Malley BW 1995 Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357
17. Takeshita A, Yen PM, Misiti S, Cardona GR, Liu Y, Chin WW 1996 Molecular cloning and properties of a full-length putative thyroid hormone receptor coactivator. Endocrinology 137:3594-3597
18. Voegel JJ, Heine MJS, Zechel C, Chambon P, Gronemeyer H 1996 TIF2, a 160 kD transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J 15:3667-3675
19. Cavailles V, Dauvois S, L'Horset F, Lopez G, Hoare S, Kushner PJ, Parker MG 1995 Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J 14:3741-3751
20. Barettino D, Ruiz Vivanco MM, Stunnenberg HG 1994 Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J 13:3039-3049
21. Tone Y, Collingwood TN, Adams M, Chatterjee VKK 1994 Functional analysis of a transactivation domain in the thyroid hormone beta receptor. J Biol Chem 269:31157-31161
22. Hayashi Y, Weiss RE, Same DH, Yen PM, Sunthomthepvarakul T, Marcocci C, Chin WW, Refetoff S 1995 Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-beta receptors? J Clin Endocrinol Metab 80:3246-3256
23. Hollenberg AN, Monden T, Madura JP, Lee K, Wondisford FE 1996 Function of nuclear co-repressor protein on thyroid hormone response elements is regulated by the receptor A/B domain. J Biol Chem 271:28516-28520
24. Ron D, Dressler H 1992 pGSTag-a versatile bacterial expression plasmid for enzymatic labeling of recombinant proteins. Biotechniques 13:866-869
25. 3) decreases DNA-binding of receptor homodimers but not receptor-auxiliary protein heterodimers. J Biol Chem 267:3565-3568
26. Nordeen SK 1988 Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques 6:454-458
27. Yen PM, Ikeda M, Brubaker JH, Forgione M, Sugawara A, Chin WW 1994 Roles of v-erbA homodimers and heterodimers in mediating dominant negative activity by v-erbA. J Biol Chem 269:903-909
28. Edlund T, Walker MD, Barr PJ, Rutter WJ 1985 Cell specific expression of the rat insulin genes: evidence for role for two distinct 5′ flanking sequences. Science 230:912-916
29. Sambrook J, Fritsch EF, Maniatis T 1989 Molecular Cloning: A Laboratory Manual, ed 2. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp 16.32-16.37
30. DeWet JR, Wood KV, DeLuca M, Helsinki DR, Subramani S 1987 Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol 7:725-737
31. Yen PM, Sunday ME, Darling DS, Chin WW 1992 Isoform-specific thyroid hormone receptor antibodies detect multiple thyroid hormone receptors in rat and human pituitaries. Endocrinology 130:1539-1546
32. Sugawara A, Yen PM, Qi YP, Lechan RM, Chin WW 1995 Isoform-specific retinoid X receptor (RXR) antibodies detect differential expression of RXR proteins in the pituitary gland. Endocrinology 136:1766-1744
33. Zamir I, Harding HP, Adkins GB, Horlein A, Glass CK, Rosenfeld MG, Lazar MA 1996 A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains. Mol Cell Biol 16:5458-5465
34. Takeshita A, Yen PM, Liu Y, Chin WW, Functional, and in vitro studies of wild-type thyroid hormone receptor and AF-2 mutants display selective effects on basal repression and transcriptional activation. International Congress of Endocrinology, San Francisco, 1996, OR1-5 (Abstract)
35. 3 receptors and transcriptional corepressors. Mol Endocrinol 11:470-480
36. Collingwood TN, Rajanayagam O, Adams M, Wagner R, Cavailles V, Kalkhoven E, Mathews C, Nystrom E, Stenlof K, Lindstedt G, Tisell L, Fletterick RJ, Parker MG, Chatterjee VKK 1997 A natural transactivation mutation in the thyroid hormone β receptor: impaired interaction with putative transcrip-tional mediators. Proc Natl Acad Sci USA 94:248-253
37. Meier CA, Dickstein BM, Ashizawa K, McClaskey JH, Muchmore P, Ransom SC, Menke JB, Hao EH, Usala SJ, Bereu BB, Cheng SY, Weintraub BD 1992 Variable transcriptional activity and ligand binding of mutant β1-3,5,3′ triiodothyronine receptors from four families with generalized resistance to thyroid hormone. Mol Endocrinol 6:248-258
38. Ercan-Fang S, Sorli CH, Cohn JN, Schwartz HL, Mariash CN, Oppenheimer JH 1996 Enlarging pituitary in a patient with thyroid hormone resistance associated with mutation E460K in the TRβ gene. Thyroid 6:S-98
39. Tone Y, Collingwood TN, Adams M, Chatterjee VKK 1994 Functional analysis of a transactivation domain in the thyroid hormone β receptor. J Biol Chem 269:31157-31161
40. Piedrafita FJ, Ortiz MA, Pfahl M 1995 Thyroid hormone receptor-beta mutants associated with generalized resistance to thyroid hormone show defects in their ligand-sensitive repression function. Mol Endocrinol 9:533-1548
41. Damm K, Evans RM 1993 Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor α. Proc Natl Acad Sci USA 90:10668-10672
42. Chen JD, Umesono K, Evans RM 1996 SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers. Proc Natl Acad Sci USA 93:7567-7571
43. Chatterjee VKK, Nagaya T, Madison LM, Datta S, Rentoumis A, Jameson JL 1991 Thyroid hormone resistance: inhibition of normal receptor function by mutant thyroid hormone receptors. J Clin Invest 87:1977-1984
44. Lin HY, Thacore HR, Davis PJ, Davis FB 1994 Thyroid hormone potentiates the antiviral action of interferon-γ in cultured human cells. J Clin Endocrinol Metab 79:62-65
45. Nagaya T, Jameson JL 1993 Thyroid hormone receptor dimerization is required for dominant negative inhibition by mutations that cause thyroid hormone resistance. J Biol Chem 268:15766-15771